The Business of Science: Scaling Pharma Innovation in a Competitive World Kumar Jeetendra | April 1, 2026 Considering the rapid evolution of our global healthcare system, the pharmaceutical sector, as a reliable source of innovative science, also serves as a resource for innovative business practices. The modern pharmaceutical sector is no longer about just discovering and innovating. It focuses on translating scientific advancements into solutions that are commercially viable. Scaling new innovations …
Alembic Pharma Wins USFDA Approval for Dapagliflozin Tablets Kumar Jeetendra | April 7, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapagliflozin Tablets, 5 mg and 10 mg. Alembic Pharmaceuticals Limited Gets USFDA Approval for Dapagliflozin Tablets The approved ANDA is therapeutically equivalent to the reference listed drug product …
Alembic Pharma Receives USFDA Approval for Haloperidol Tablets Kumar Jeetendra | June 5, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Haldol …
2026 Watchlist: Top 10 CROs Driving Innovation in Drug Development Kumar Jeetendra | June 24, 2026 The role of AI in research promises to bring new drugs to market faster than ever before. Drug development is complex. As a result, many of the best contract research organizations (CROs) have stopped being simple vendors or service delivery partners. They have become partners in strategic innovation. The CRO Leaders to Watch in 2026: …
